tirzepatide law office in dallas Alliance Defending Freedom opens new – Alliance Defending Freedom dallas semaglutide intestinal paralysis law

Background and FDAs Announcement FDA's April 1, 2026, update to its compounding policy page follows more than 18 months of regulatory activity surrounding the compounding of GLP-1 medications, primarily semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound)

Pre-switch assessment by your doctor Before switching, your doctor will do an assessment

Urethra (the tube carrying urine out of the body) from irritation, trauma, or infection

Cardiovascular Risk Reduction: Seglutide can reduce the risk of major cardiovascular events like heart attack, stroke, or death in adults with type 2 diabetes and known heart disease

Tirzepatide remains the reference molecule for protocols that need the deepest published evidence base today